Epidemiology and outcomes of Candida spp. bloodstream infections in cancer patients: a comparative retrospective study from a German tertiary cancer center
Compared to bacterial BSI events, Candida BSI are associated with significantly higher 30-day mortality, primarily affecting heavily pretreated patients with relapsed or refractory disease.
Authors
- Thomas Oellerich (ORCID: https://orcid.org/0000-0001-6570-6125)
- Volkhard A. J. Kempf (ORCID: https://orcid.org/0000-0002-3321-7551)
- Björn Steffen
- Friederike Klein
- Sarah Weber (ORCID: https://orcid.org/0000-0002-9624-1399)
- Jörg Janne Vehreschild (ORCID: https://orcid.org/0000-0002-5446-7170)
- Johanna Kessel (ORCID: https://orcid.org/0000-0003-3246-5219)
- Julius C. Enßle (ORCID: https://orcid.org/0000-0003-0351-5942)
- Michael Hogardt (ORCID: https://orcid.org/0000-0002-0742-950X)
- Sebastian Scheich (ORCID: https://orcid.org/0000-0001-6408-3536)
- Hubert Serve (ORCID: https://orcid.org/0000-0001-8472-5516)
- Sebastian Wolf
- Aaron Janetta
Institutions
- Goethe University Frankfurt (DE)
- University Hospital Frankfurt (DE)
- Frankfurt Cancer Institute (DE)
Publication Details
- Journal
- Infection
- Published
- 2025-04-02
- DOI
- https://doi.org/10.1007/s15010-025-02513-z
- Citations
- 3
- Primary Topic
- Antifungal resistance and susceptibility
- Type
- article
- Field-Weighted Citation Impact
- 4.19
Funders
- Deutsche Krebshilfe